Zobrazeno 1 - 10
of 82
pro vyhledávání: '"D, Terkieltaub"'
Autor:
E. Brener, T. Mashriki, M. McGrath, L. Marchal, E. Ella, M. Moran, S. Leibman Barak, B. Vaisman, D. Terkieltaub, N. Schutz, A. Hovnanian, L. Braiman
Publikováno v:
Journal of Investigative Dermatology. 143:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa687f7937fea9d20704c515d09c97d5
https://doi.org/10.1016/j.jid.2023.03.1116
https://doi.org/10.1016/j.jid.2023.03.1116
Publikováno v:
In Antiviral Research 2000 46(1):A63-A63
Publikováno v:
In Antiviral Research 2000 46(1):A56-A56
Autor:
Eithan Galun, Shlomo Dagan, Rachel Buchnik, Ludmila Rivkin, Yael Liberman, D. Terkieltaub, Sara Misrachi, Meirav Zohar, Rachel Eren, Yaffa Ashur, Rifaat Safadi, Arie Zauberman, Norah A. Terrault, Ofer Nussbaum, Zvi Ackerman
Publikováno v:
Journal of Hepatology. 46:37-44
Background/Aims: HCV-AB68, a human monoclonal antibody against the envelope protein of hepatitis C virus (HCV), neutralizes HCV in cell-culture and in the HCV-Trimera mouse model. A Phase 1 clinical trial was designed to test safety, tolerability, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce158016da331b70163aeb47af85246c
https://doi.org/10.1016/j.jhep.2006.08.019
https://doi.org/10.1016/j.jhep.2006.08.019
Autor:
Emmet B. Keeffe, Norah A. Terrault, D. Terkieltaub, Eithan Galun, Edith Matot, Yaffa Ashour, Daniel Shouval, Sara Mizrachi, Shlomo Dagan, Rachel Eren, Rifaat Safadi, Ido Lubin, Merav Zohar, Judith Gopher
Publikováno v:
Hepatology. 35:673-679
Treatment of chronic hepatitis B virus (HBV) infection with interferon alfa and lamivudine is characterized by lack of viral clearance, loss of response, or emergence of drug-resistant mutants. Thus, new and multiple drug approaches are needed. We ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9217e6caaf69b2dc07870e2c68df97dd
https://doi.org/10.1053/jhep.2002.31867
https://doi.org/10.1053/jhep.2002.31867
Autor:
Rachel Eren, Eithan Galun, Shoshana Berr, Arie Zauberman, Berit Hammas, Ahamed Eid, Oded Jurim, D. Terkieltaub, Lars O. Magnius, Ofer Nussbaum, Shlomo Dagan, Danny Shouval, Yossi Arazi, Ofer Ben-Moshe, Nili Daudi, Yair Reisner, Ehud Ilan, Ido Lubin, Judy Gopher, Alberto Kitchinzky
Publikováno v:
Hepatology. 32:588-596
Two human monoclonal antibodies (mAbs) against hepatitis B surface antigen (HBsAg) generated in the Trimera mouse system are described. Both mAbs 17.1.41 and 19.79.5 are of the IgG1 isotype and have high affinity constants for HBsAg binding in the ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe528f4ad2cd079962f9d010ca5f12c8
https://doi.org/10.1053/jhep.2000.9632
https://doi.org/10.1053/jhep.2000.9632
Autor:
Yair Reisner, Eithan Galun, Daniel Shouval, Wulf O. Böcher, Hanns F. Löhr, Nili Daudi, Hadar Marcus, D. Terkieltaub
Publikováno v:
Hepatology. 31:480-487
In chronic hepatitis B virus (HBV) infection weak antiviral immune responses are associated with viral persistence. We studied possible immune deficits underlying the lack of serum antibodies of such patients against the HBV surface antigen (HBsAg) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7164fc2a199fdb615580715b29c98f85
https://doi.org/10.1002/hep.510310231
https://doi.org/10.1002/hep.510310231
Autor:
Daniel Shouval, D. Terkieltaub, Rachel Eren, Eithan Galun, Ofer Ben-Moshe, Hadar Marcus, Yair Reisner, Ehud Ilan, T Tzahor, S Moss, Ido Lubin, Arie Zauberman, Nili Daudi, R Uhlmann, Shlomo Dagan
Publikováno v:
Immunology. 93:154-161
An approach to develop fully human monoclonal antibodies in a human/mouse radiation chimera, the Trimera system, is described. In this system, functional human lymphocytes are engrafted in normal strains of mice which are rendered immuno-incompetent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f7070b0c73fac0f16ac811d2e18f131
https://doi.org/10.1046/j.1365-2567.1998.00426.x
https://doi.org/10.1046/j.1365-2567.1998.00426.x
Autor:
Ahmed Eid, Zhen-Yong Keck, Riva Kovjazin, Ofer Ben-Moshe, Oded Jurim, G Zamir, Alberto Kischitsky, D. Terkieltaub, Rachel Eren, Steven K. H. Foung, Ziva Rosenthal-Galili, Judith Ben-Porath, Yariv Shoshany, Sigal Aviel, Rachel Buchnick, Shlomo Dagan, Ofer Nussbaum, Dorit Landstein, Eithan Galun, Ehud Ilan, Judith Gopher, Arie Zauberman, Tal Waisman, Lewis Neville, Orit Pappo
Passive immunotherapy is potentially effective in preventing reinfection of liver grafts in hepatitis C virus (HCV)-associated liver transplant patients. A combination of monoclonal antibodies directed against different epitopes may be advantageous a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91dcbb4a54241612f1baa23ce02ab1d
https://europepmc.org/articles/PMC1395448/
https://europepmc.org/articles/PMC1395448/
Autor:
W O, Böcher, E, Galun, H, Marcus, N, Daudi, D, Terkieltaub, D, Shouval, H F, Löhr, Y, Reisner
Publikováno v:
Hepatology (Baltimore, Md.). 31(2)
In chronic hepatitis B virus (HBV) infection weak antiviral immune responses are associated with viral persistence. We studied possible immune deficits underlying the lack of serum antibodies of such patients against the HBV surface antigen (HBsAg) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76eae69d4aef0fb9e437079fbbc8ff08
https://pubmed.ncbi.nlm.nih.gov/10655274
https://pubmed.ncbi.nlm.nih.gov/10655274